COO vs HQY
Cooper Companies (The) vs HealthEquity — AI-powered side-by-side comparison
COO
Cooper Companies (The)
67
Buy
VS
| Metric | COO | HQY |
|---|
| AI Score |
67
|
64
|
| Price |
$76.31
|
$106.83
|
| P/E Ratio |
62.91×
|
38.75×
|
| ROE |
4.6%
|
10.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
64.4%
|
72.7%
|
| Debt / Equity |
0.30×
|
0.48×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
61.8
|
65.8
|
| Beta |
0.823
|
0.21
|
| Expected Upside |
+0.2%
|
+1.0%
|
AI Committee View
Current Innellis committee reasoning for COO versus HQY.
COO leads by 3 points.
COO scores 67/100 (Buy) versus HQY at 64/100 (Buy).
COO Committee View
75% agreement
4 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Risk/reward is unfavorable: 4.4% downside vs 0.2% upside.
HQY Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 4 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 15.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Weekly RSI at 76 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 15.3% signals elevated volatility — Risk